Radical surgery trial aims to extend control of spreading prostate cancer
NCT ID NCT07268794
Summary
This study is for men whose prostate cancer has already spread to other parts of the body when first diagnosed. It tests whether adding surgery to remove the prostate (or radiation) to standard drug therapy helps control the cancer for a longer time without it getting worse, compared to using drug therapy alone. All participants first get 6 months of strong drug therapy. Those who respond very well are then randomly assigned to either continue just the drugs, or to have the prostate removed/radiated while continuing the drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.